CYTOKINETICS, INCORPORATED and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of July 6, 2022 3.50% Convertible Senior Notes due 2027Cytokinetics, Incorporated • July 6th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of July 6, 2022, between Cytokinetics, Incorporated, a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
